Whilst there has been some good discussion lately I thought it would be worth starting a new thread for those who have had enough of what has happened and want to move on to the near future and some positives.
Some things to look forward to IMO are.
- The company will have phase 2 atopic dermatitis trial results out Q1 2019. This treatment uses a completely different formulation to the BTX 1503 acne trial
- The company still intends to take the phase 2 acne trial to phase 3.
- The phase 2 acne trial was one of the safest ever conducted.
- The company received $40m in capital in early August, including $35m from U.S. institutional clients
- Botanix has signed a cannabidiol supply agreement with industry leader Purisys through to December 2027
BOT: Moving Forward
-
- There are more pages in this discussion • 95 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
0.015(4.17%) |
Mkt cap ! $590.6M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 40.0¢ | 36.5¢ | $10.56M | 27.45M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 75348 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 514698 | 3 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| BOT (ASX) Chart |